PMPaul-Jun Martial

Paul-Jun Martial

*This is an algorithmically generated author record based on publicly available information.

Paul-Jun Martial has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandre Unger

    Université Paris Cité, Department of Cardiology, University Hospital of Lariboisiere, France (J.H., S.T., T.G., A.U., J.F., J.-G.D., T.P.).

    3 shared publications
  • Francesca Sanguineti

    Institut Cardiovasculaire Paris-Sud, Hôpital Jacques Cartier, 91300 Massy, France

    3 shared publications
  • Jeremy Florence

    MIRACL.ai laboratory, Multimodality Imaging for Research and Analysis Core Laboratory-Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France

    3 shared publications
  • Jérôme Garot

    MIRACL.ai laboratory, Multimodality Imaging for Research and Artificial Intelligence Core Laboratory (J.H., J.G., S.T., T.G., A.U., J.F., J.-G.D., T.P., Y.B.), University Hospital of Lariboisiere (AP-HP), Paris, France

    3 shared publications
  • Philippe Garot

    Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, 91300 Massy, France

    3 shared publications
  • Suzanne Duhamel

    Institut Cardiovasculaire Paris Sud, Cardiovascular Magnetic Resonance Laboratory, Hôpital Privé Jacques CARTIER, Ramsay Santé, Massy, France (J.G., S.D., F.S., P.G., T.H., S.C., T.U., M.A., A.N., T.G.).

    3 shared publications

Latest Publications

  • Stress CMR ischaemic burden and long-term mortality in left ventricular systolic dysfunction: a multicentre registry study

    by Alexandre Pfeffer, JérÔme Garot, Suzanne Duhamel, Philippe Garot, Francesca Sanguineti, Thomas Hovasse, StépHane Champagne, Thierry Unterseeh, Mariama Akodad, Antoinette Neylon, et al.

    Aims: Stress perfusion cardiovascular magnetic resonance (CMR) integrates the assessment of myocardial ischaemia, scar, and function. Its incremental prognostic value in patients with left ventricular (LV) systolic dysfunction remains uncertain. Methods and results: We analysed a prospective multicentre registry of consecutive patients undergoing vasodilator stress perfusion CMR at three French centres (2008–24). Patients with CMR-derived LVEF < 50% were included. The primary end point was all-cause mortality. Associations were estimated with multivariable Cox models. Incremental prognostic value of ischaemia and late gadolinium enhancement (LGE) beyond clinical factors and LVEF was assessed by likelihood ratio χ2, continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Among 5977 patients (79% men; age 66 ± 12 years, mean LVEF 42 ± 7%), inducible ischaemia was present in 19% (mean extent 2.4 ± 1.2 segments). Over a median follow-up of 9 years, 1343 patients (22%) died. Ischaemic segment extent was independently associated with mortality (HR per segment 1.11; 95% CI, 1.06–1.15; P < 0.001). Adding ischaemia and LGE to clinical factors and LVEF improved model fit and reclassification (global χ2 increased from 707 to 728; NRI 0.217; IDI 0.004; all P < 0.001). Findings were consistent across LVEF subgroups (40–50% and <40%). In secondary analyses among patients with ischaemia, outcomes differed by subsequent revascularization status; these findings are observational and hypothesis-generating. Conclusion: In patients with LVEF < 50%, ischaemic burden on stress CMR is independently associated with long-term mortality beyond clinical factors, LVEF and LGE. Integrating ischaemia and scar metrics provides incremental prognostic information that may aid risk stratification using stress CMR in LV systolic dysfunction.

  • Stress Perfusion CMR Imaging-Guided Management and Prognosis in Patients With Suspected Coronary Heart Disease

    by Antonin Trimaille, Philippe Garot, Solenn Toupin, Francesca Sanguineti, Thomas Hovasse, Suzanne Duhamel, StépHane Champagne, Thierry Unterseeh, Mariama Akodad, Antoinette Neylon, et al.

    BACKGROUND: Identifying patients with chronic coronary syndrome who will benefit most from a coronary revascularization strategy is essential. Data on the performance of stress cardiac magnetic resonance (CMR) to guide revascularization are limited. To assess the long-term prognostic impact of stress CMR-guided revascularization strategy to predict all-cause death. METHODS: We conducted an observational study including all consecutive patients who underwent stress CMR for suspected or known chronic coronary syndrome in 3 centers in France. CMR-guided coronary revascularization was defined as any revascularization performed within 90 days following stress CMR. The primary outcome was all-cause death. RESULTS: A total of 50 701 patients were included (mean age, 64±12 years; 68.5% men). After a median follow-up of 7.2 years (interquartile range, 3.0–11.0), 3665 (7.2%) patients died. Among the 7396 patients with ischemia, 6523 (88%) underwent revascularization. Ischemia and late gadolinium enhancement (LGE) without viability were independent predictors of death (adjusted hazard ratio, 3.67 [99.5% CI, 3.15–4.27] and adjusted hazard ratio, 1.26 [99.5% CI, 1.10–1.44], respectively; P P P P =0.23). CONCLUSIONS: In this registry of consecutive patients with chronic coronary syndrome from 3 centers, stress CMR-guided revascularization was associated with a lower rate of death. The combined assessment of inducible myocardial ischemia and LGE may help to select patients most suitable for revascularization.


  • Prognostic Value of Cardiac MRI Late Gadolinium Enhancement Granularity in Participants with Ischemic Cardiomyopathy

    by Alexandre Unger, Jérôme Garot, Solenn Toupin, Suzanne Duhamel, Francesca Sanguineti, Thomas Hovasse, Stéphane Champagne, Thierry Unterseeh, Bernard Chevalier, Mariama Akodad, et al.

    A cardiac MRI model incorporating the ischemic late gadolinium enhancement (LGE) parameters of extent, transmurality, location, and midwall LGE significantly outperformed traditional risk factors in predicting all-cause mortality in participants with ischemic cardiomyopathy.